With the increasing prevalence of pneumococcal diseases, government organizations across various countries are introducing programs to promote the use of pneumococcal vaccines. For instance, UNICEF along with the WHO has launched the Global Action Plan for Pneumonia and Diarrhea (GAPPD) to control incidence and mortality rate in children suffering from severe diarrhea and pneumonia by 2025. The investment in developing countries has also increased to help in the development and delivery of vaccines. For example, GAVI is a vaccine alliance that brings together public and private sector to offer immunization to the children in world’s poorest countries.
The high cost of advanced vaccines is one of the factors hampering the growth of the market. However, manufacturers are competing for development of cost-effective and high quality of vaccines by focusing on research and development activities.
According to the report by Transparency Market Research (TMR), the global market for pneumococcal vaccines is likely to witness robust growth, registering 8.3% CAGR between 2017 and 2026. The global market for pneumococcal vaccines is also projected to bring in US$ 20,515.5 million revenue by 2026 end.
13- Valent PCV to be the Top-Selling Product in the Global Market for Pneumococcal Vaccines
Compared to the various products, 13- valent PCV is likely to emerge as one of the top-selling product in the global market for pneumococcal vaccines. By 2026 end, 13- valent PCV is projected to bring in close to US$ 9,500 million revenue. PVC13 has offered a significant benefit in reducing carriage of Antibiotic-Nonsusceptible Streptococcus Pneumoniae (ANSP). Moreover, 13- Valent PCV includes thirteen serotypes of pneumococcus, also, serotypes 19A and 6A are present only in PCV13. The Centers for Disease Control and Prevention (CDC) has also recommended PCV13 for adults above the 65 years of age.
Hospitals to Emerge as the Largest Distribution Channel
Pneumococcal vaccines are likely to be distributed by Hospitals on a large scale between 2017 and 2026. Hospitals are projected to surpass US$ 12,400 million revenue towards the end of 2026. Increasing number of patients are being hospitalized for various infections and diseases, hence hospitals are emerging as the biggest distribution channel for pneumococcal vaccines, thereby reducing mortality associated with the pneumococcal infection.
North America to be the Largest Region in the Global Market for Pneumococcal Vaccines
North America is likely to emerge as one of the biggest regions in the global market for pneumococcal vaccines during 2017-2026. Pneumococcal Conjugated Vaccine (PCV) is the part of routine vaccine immunization in Canada and the U.S., since 2000. The countries have also witnessed highly-effective results since the vaccine was introduced. Investments by the government organization and private companies have also increased for promoting vaccination and towards the research and development of new vaccines. North America has also emerged as a main center for many vaccine producing companies.
Meanwhile, PCV is also the part of the vaccination program in countries like the Netherlands, Germany, Slovakia, Albania, Greece and Serbia. Increasing incidence of pneumococcal disease in various countries in APEJ also presents an opportunity for companies producing pneumococcal vaccines. Brazil is also witnessing a significant increase in pneumococcal diseases. Hence, various programs are being introduced in Brazil to increase the vaccine coverage.
Competition Tracking
The report provides a detailed analysis of the leading companies operating in the global market for pneumococcal vaccines such as Merck & Co. Inc., Pfizer, Inc., Sanofi, and GlaxoSmithKline PLC. The companies are focusing on the research and development of new pneumococcal vaccines. There has also been an increase in partnership between the leading companies and distributors in order to expand in the global market.
1. Global Economic Outlook
2. Global Pneumococcal Vaccines Market - Executive Summary
3. Global Pneumococcal Vaccines Market Overview
3.1. Introduction
3.1.1. Global Pneumococcal Vaccines Market Taxonomy
3.1.2. Global Pneumococcal Vaccines Market Definition
3.2. Global Pneumococcal Vaccines Market Size (US$ Mn) and Forecast, 2012-2026
3.2.1. Global Pneumococcal Vaccines Market Y-o-Y Growth
3.3. Global Pneumococcal Vaccines Market Dynamics
3.4. Supply Chain
3.5. Cost Structure
3.6. Pricing Analysis
3.7. PESTL Analysis
3.8. Product Life Cycle Analysis
3.9. Epidemiology
3.10. Coverage Rates By Pneumococcal Conjugate Vaccines (PCV) Against Invasive Pneumococcal Disease In Children Of Different Age Groups
3.11. Key Regulations
3.12. PATENT
3.13. List of Distributors
3.14. Key Participants Market Presence (Intensity Map) By Region
4. Global Pneumococcal Vaccines Market Analysis and Forecast 2012-2026
4.1. Global Pneumococcal Vaccines Market Size and Forecast By Product Type, 2012-2026
4.1.1. 7- Valent PCV Market Size and Forecast, 2012-2026
4.1.1.1. Revenue (US$ Mn) Comparison, By Region
4.1.1.2. Market Share Comparison, By Region
4.1.1.3. Y-o-Y growth Comparison, By Region
4.1.2. 10- Valent PCV Market Size and Forecast, 2012-2026
4.1.2.1. Revenue (US$ Mn) Comparison, By Region
4.1.2.2. Market Share Comparison, By Region
4.1.2.3. Y-o-Y growth Comparison, By Region
4.1.3. 13- Valent PCV Market Size and Forecast, 2012-2026
4.1.3.1. Revenue (US$ Mn) Comparison, By Region
4.1.3.2. Market Share Comparison, By Region
4.1.3.3. Y-o-Y growth Comparison, By Region
4.1.4. 23- Valent PPSV Market Size and Forecast, 2012-2026
4.1.4.1. Revenue (US$ Mn) Comparison, By Region
4.1.4.2. Market Share Comparison, By Region
4.1.4.3. Y-o-Y growth Comparison, By Region
4.2. Global Pneumococcal Vaccines Market Size and Forecast By Distribution Channel, 2012-2026
4.2.1. Hospitals Market Size and Forecast, 2012-2026
4.2.1.1. Revenue (US$ Mn) Comparison, By Region
4.2.1.2. Market Share Comparison, By Region
4.2.1.3. Y-o-Y growth Comparison, By Region
4.2.2. Clinics Market Size and Forecast, 2012-2026
4.2.2.1. Revenue (US$ Mn) Comparison, By Region
4.2.2.2. Market Share Comparison, By Region
4.2.2.3. Y-o-Y growth Comparison, By Region
4.2.3. Other End Users Market Size and Forecast, 2012-2026
4.2.3.1. Revenue (US$ Mn) Comparison, By Region
4.2.3.2. Market Share Comparison, By Region
4.2.3.3. Y-o-Y growth Comparison, By Region
5. North America Pneumococcal Vaccines Market Size and Forecast, 2012-2026
5.1. North America Outlook
5.2. North America Parent Market Outlook
5.3. North America Target Market Outlook
5.4. Revenue (US$ Mn) Comparison, By Country
5.4.1. US Market Size and Forecast (US$ Mn), 2012-2026
5.4.2. Canada Market Size and Forecast (US$ Mn), 2012-2026
5.5. Revenue (US$ Mn) Comparison, By Product Type
5.6. Revenue (US$ Mn) Comparison, By Distribution Channel
6. Latin America Pneumococcal Vaccines Market Size and Forecast, 2012-2026
6.1. Latin America Outlook
6.2. Latin America Parent Market Outlook
6.3. Latin America Target Market Outlook
6.4. Revenue (US$ Mn) Comparison, By Country
6.4.1. Brazil Market Size and Forecast (US$ Mn), 2012-2026
6.4.2. Mexico Market Size and Forecast (US$ Mn), 2012-2026
6.4.3. Rest of Latin America Market Size and Forecast (US$ Mn), 2012-2026
6.5. Revenue (US$ Mn) Comparison, By Product Type
6.6. Revenue (US$ Mn) Comparison, By Distribution Channel
7. Europe Pneumococcal Vaccines Market Size and Forecast, 2012-2026
7.1. Europe Outlook
7.2. Europe Parent Market Outlook
7.3. Europe Target Market Outlook
7.4. Revenue (US$ Mn) Comparison, By Country
7.4.1. Germany Market Size and Forecast (US$ Mn), 2012-2026
7.4.2. UK Market Size and Forecast (US$ Mn), 2012-2026
7.4.3. France Market Size and Forecast (US$ Mn), 2012-2026
7.4.4. Spain Market Size and Forecast (US$ Mn), 2012-2026
7.4.5. Italy Market Size and Forecast (US$ Mn), 2012-2026
7.4.6. Rest of Europe Market Size and Forecast (US$ Mn), 2012-2026
7.5. Revenue (US$ Mn) Comparison, By Product Type
7.6. Revenue (US$ Mn) Comparison, By Distribution Channel
8. Japan Pneumococcal Vaccines Market Size and Forecast, 2012-2026
8.1. Japan Outlook
8.2. Japan Parent Market Outlook
8.3. Japan Target Market Outlook
8.4. Revenue (US$ Mn) Comparison, By Country
8.4.1. Japan Market Size and Forecast (US$ Mn), 2012-2026
8.5. Revenue (US$ Mn) Comparison, By Product Type
8.6. Revenue (US$ Mn) Comparison, By Distribution Channel
9. APEJ Pneumococcal Vaccines Market Size and Forecast, 2012-2026
9.1. APEJ Outlook
9.2. APEJ Parent Market Outlook
9.3. APEJ Target Market Outlook
9.4. Revenue (US$ Mn) Comparison, By Country
9.4.1. China Market Size and Forecast (US$ Mn), 2012-2026
9.4.2. India Market Size and Forecast (US$ Mn), 2012-2026
9.4.3. Thailand Market Size and Forecast (US$ Mn), 2012-2026
9.4.4. Singapore Market Size and Forecast (US$ Mn), 2012-2026
9.4.5. Australia Market Size and Forecast (US$ Mn), 2012-2026
9.4.6. Rest of APEJ Market Size and Forecast (US$ Mn), 2012-2026
9.5. Revenue (US$ Mn) Comparison, By Product Type
9.6. Revenue (US$ Mn) Comparison, By Distribution Channel
10. MEA Pneumococcal Vaccines Market Size and Forecast, 2012-2026
10.1. MEA Outlook
10.2. MEA Parent Market Outlook
10.3. MEA Target Market Outlook
10.4. Revenue (US$ Mn) Comparison, By Country
10.4.1. GCC Countries Market Size and Forecast (US$ Mn), 2012-2026
10.4.2. South Africa Market Size and Forecast (US$ Mn), 2012-2026
10.4.3. Israel Market Size and Forecast (US$ Mn), 2012-2026
10.4.4. Rest of MEA Market Size and Forecast (US$ Mn), 2012-2026
10.5. Revenue (US$ Mn) Comparison, By Product Type
10.6. Revenue (US$ Mn) Comparison, By Distribution Channel
11. Global Pneumococcal Vaccines Market Company Share, Competition Landscape and Company Profiles
11.1. Company Share Analysis
11.2. Competition Landscape
11.3. Company Profiles
11.3.1. Pfizer, Inc.
11.3.2. GlaxoSmithKline PLC
11.3.3. Merck & Co., Inc.
11.3.4. Sanofi
11.4. Key Takeaways
12. Research Methodology
13. Disclaimer
List of Tables
TABLE 1 Global Pneumococcal Vaccines Market Value (US$ Mn), 2012-2017
TABLE 2 Global Pneumococcal Vaccines Market Value (US$ Mn), 2018-2026
TABLE 3 Global Pneumococcal Vaccines Market Value (US$ Mn) and Y-o-Y, 2017-2026
TABLE 4 Global 7- Valent PCV Segment Value (US$ Mn), By Region 2012-2017
TABLE 5 Global 7- Valent PCV Segment Value (US$ Mn), By Region 2018-2026
TABLE 6 Global 7- Valent PCV Segment Market Share, By Region 2012-2017
TABLE 7 Global 7- Valent PCV Segment Market Share, By Region 2018-2026
TABLE 8 Global 7- Valent PCV Segment Y-o-Y, By Region 2017-2026
TABLE 9 Global 10- Valent PCV Segment Value (US$ Mn), By Region 2012-2017
TABLE 10 Global 10- Valent PCV Segment Value (US$ Mn), By Region 2018-2026
TABLE 11 Global 10- Valent PCV Segment Market Share, By Region 2012-2017
TABLE 12 Global 10- Valent PCV Segment Market Share, By Region 2018-2026
TABLE 13 Global 10- Valent PCV Segment Y-o-Y, By Region 2017-2026
TABLE 14 Global 13- Valent PCV Segment Value (US$ Mn), By Region 2012-2017
TABLE 15 Global 13- Valent PCV Segment Value (US$ Mn), By Region 2018-2026
TABLE 16 Global 13- Valent PCV Segment Market Share, By Region 2012-2017
TABLE 17 Global 13- Valent PCV Segment Market Share, By Region 2018-2026
TABLE 18 Global 13- Valent PCV Segment Y-o-Y, By Region 2017-2026
TABLE 19 Global 23- Valent PPSV Segment Value (US$ Mn), By Region 2012-2017
TABLE 20 Global 23- Valent PPSV Segment Value (US$ Mn), By Region 2018-2026
TABLE 21 Global 23- Valent PPSV Segment Market Share, By Region 2012-2017
TABLE 22 Global 23- Valent PPSV Segment Market Share, By Region 2018-2026
TABLE 23 Global 23- Valent PPSV Segment Y-o-Y, By Region 2017-2026
TABLE 24 Global Hospitals Segment Value (US$ Mn), By Region 2012-2017
TABLE 25 Global Hospitals Segment Value (US$ Mn), By Region 2018-2026
TABLE 26 Global Hospitals Segment Market Share, By Region 2012-2017
TABLE 27 Global Hospitals Segment Market Share, By Region 2018-2026
TABLE 28 Global Hospitals Segment Y-o-Y, By Region 2017-2026
TABLE 29 Global Clinics Segment Value (US$ Mn), By Region 2012-2017
TABLE 30 Global Clincs Segment Value (US$ Mn), By Region 2018-2026
TABLE 31 Global Clincs Segment Market Share, By Region 2012-2017
TABLE 32 Global Clincs Segment Market Share, By Region 2018-2026
TABLE 33 Global Clincs Segment Y-o-Y, By Region 2017-2026
TABLE 34 Global Other End Users Segment Value (US$ Mn), By Region 2012-2017
TABLE 35 Global Other End Users Segment Value (US$ Mn), By Region 2018-2026
TABLE 36 Global Other End Users Segment Market Share, By Region 2012-2017
TABLE 37 Global Other End Users Segment Market Share, By Region 2018-2026
TABLE 38 Global Other End Users Segment Y-o-Y, By Region 2017-2026
TABLE 39 North America Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016
TABLE 40 North America Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016
TABLE 41 North America Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016
TABLE 42 North America Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016
TABLE 43 North America Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016
TABLE 44 North America Pneumococcal Vaccines Market Value (US$ Mn), By Country 2012-2017
TABLE 45 North America Pneumococcal Vaccines Market Value (US$ Mn), By Country 2018-2026
TABLE 46 North America Pneumococcal Vaccines Market Value (US$ Mn), By Product Type 2012-2017
TABLE 47 North America Pneumococcal Vaccines Market Value (US$ Mn), By Product Type 2018-2026
TABLE 48 North America Pneumococcal Vaccines Market Value (US$ Mn), By Distribution Channel 2012-2017
TABLE 49 North America Pneumococcal Vaccines Market Value (US$ Mn), By Distribution Channel 2018-2026
TABLE 50 Latin America Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016
TABLE 51 Latin America Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016
TABLE 52 Latin America Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016
TABLE 53 Latin America Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016
TABLE 54 Latin America Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016
TABLE 55 Latin America Pneumococcal Vaccines Market Value (US$ Mn), By Country 2012-2017
TABLE 56 Latin America Pneumococcal Vaccines Market Value (US$ Mn), By Country 2018-2026
TABLE 57 Latin America Pneumococcal Vaccines Market Value (US$ Mn), By Product Type 2012-2017
TABLE 58 Latin America Pneumococcal Vaccines Market Value (US$ Mn), By Product Type 2018-2026
TABLE 59 Latin America Pneumococcal Vaccines Market Value (US$ Mn), By Distribution Channel 2012-2017
TABLE 60 Latin America Pneumococcal Vaccines Market Value (US$ Mn), By Distribution Channel 2018-2026
TABLE 61 Europe Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016
TABLE 62 Europe Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016
TABLE 63 Europe Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016
TABLE 64 Europe Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016
TABLE 65 Europe Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016
TABLE 66 Europe Pneumococcal Vaccines Market Value (US$ Mn), By Country 2012-2017
TABLE 67 Europe Pneumococcal Vaccines Market Value (US$ Mn), By Country 2018-2026
TABLE 68 Europe Pneumococcal Vaccines Market Value (US$ Mn), By Product Type 2012-2017
TABLE 69 Europe Pneumococcal Vaccines Market Value (US$ Mn), By Product Type 2018-2026
TABLE 70 Europe Pneumococcal Vaccines Market Value (US$ Mn), By Distribution Channel 2012-2017
TABLE 71 Europe Pneumococcal Vaccines Market Value (US$ Mn), By Distribution Channel 2018-2026
TABLE 72 Japan Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016
TABLE 73 Japan Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016
TABLE 74 Japan Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016
TABLE 75 Japan Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016
TABLE 76 Japan Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016
TABLE 77 Japan Pneumococcal Vaccines Market Value (US$ Mn), By Country 2012-2017
TABLE 78 Japan Pneumococcal Vaccines Market Value (US$ Mn), By Country 2018-2026
TABLE 79 Japan Pneumococcal Vaccines Market Value (US$ Mn), By Product Type 2012-2017
TABLE 80 Japan Pneumococcal Vaccines Market Value (US$ Mn), By Product Type 2018-2026
TABLE 81 Japan Pneumococcal Vaccines Market Value (US$ Mn), By Distribution Channel 2012-2017
TABLE 82 Japan Pneumococcal Vaccines Market Value (US$ Mn), By Distribution Channel 2018-2026
TABLE 83 APEJ Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016
TABLE 84 APEJ Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016
TABLE 85 APEJ Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016
TABLE 86 APEJ Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016
TABLE 87 APEJ Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016
TABLE 88 APEJ Pneumococcal Vaccines Market Value (US$ Mn), By Country 2012-2017
TABLE 89 APEJ Pneumococcal Vaccines Market Value (US$ Mn), By Country 2018-2026
TABLE 90 APEJ Pneumococcal Vaccines Market Value (US$ Mn), By Product Type 2012-2017
TABLE 91 APEJ Pneumococcal Vaccines Market Value (US$ Mn), By Product Type 2018-2026
TABLE 92 APEJ Pneumococcal Vaccines Market Value (US$ Mn), By Distribution Channel 2012-2017
TABLE 93 APEJ Pneumococcal Vaccines Market Value (US$ Mn), By Distribution Channel 2018-2026
TABLE 94 MEA Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016
TABLE 95 MEA Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016
TABLE 96 MEA Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016
TABLE 97 MEA Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016
TABLE 98 MEA Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016
TABLE 99 MEA Pneumococcal Vaccines Market Value (US$ Mn), By Country 2012-2017
TABLE 100 MEA Pneumococcal Vaccines Market Value (US$ Mn), By Country 2018-2026
TABLE 101 MEA Pneumococcal Vaccines Market Value (US$ Mn), By Product Type 2012-2017
TABLE 102 MEA Pneumococcal Vaccines Market Value (US$ Mn), By Product Type 2018-2026
TABLE 103 MEA Pneumococcal Vaccines Market Value (US$ Mn), By Distribution Channel 2012-2017
TABLE 104 MEA Pneumococcal Vaccines Market Value (US$ Mn), By Distribution Channel 2018-2026
List of Figures
FIG. 1 Global Pneumococcal Vaccines Market Value (US$ Mn), 2012-2017
FIG. 2 Global Pneumococcal Vaccines Market Value (US$ Mn) Forecast, 2018-2026
FIG. 3 Global Pneumococcal Vaccines Market Value (US$ Mn) and Y-o-Y, 2017-2026
FIG. 4 Global 7- Valent PCV Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 5 Global 7- Valent PCV Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 6 Global 7- Valent PCV Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 7 Global 10- Valent PCV Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 8 Global 10- Valent PCV Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 9 Global 10- Valent PCV Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 10 Global 13- Valent PCV Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 11 Global 13- Valent PCV Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 12 Global 13- Valent PCV Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 13 Global 23- Valent PPSV Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 14 Global 23- Valent PPSV Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 15 Global 23- Valent PPSV Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 16 Global Hospitals Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 17 Global Hospitals Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 18 Global Hospitals Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 19 Global Clincs Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 20 Global Clincs Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 21 Global Clincs Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 22 Global Other End Users Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 23 Global Other End Users Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 24 Global Other End Users Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 25 North America Pneumococcal Vaccines Market Value (US$ Mn), By Country 2012-2017
FIG. 26 North America Pneumococcal Vaccines Market Value (US$ Mn), By Country 2018-2026
FIG. 27 North America Pneumococcal Vaccines Market Value (US$ Mn), By Product Type 2012-2017
FIG. 28 North America Pneumococcal Vaccines Market Value (US$ Mn), By Product Type 2018-2026
FIG. 29 North America Pneumococcal Vaccines Market Value (US$ Mn), By Distribution Channel 2012-2017
FIG. 30 North America Pneumococcal Vaccines Market Value (US$ Mn), By Distribution Channel 2018-2026
FIG. 31 Latin America Pneumococcal Vaccines Market Value (US$ Mn), By Country 2012-2017
FIG. 32 Latin America Pneumococcal Vaccines Market Value (US$ Mn), By Country 2018-2026
FIG. 33 Latin America Pneumococcal Vaccines Market Value (US$ Mn), By Product Type 2012-2017
FIG. 34 Latin America Pneumococcal Vaccines Market Value (US$ Mn), By Product Type 2018-2026
FIG. 35 Latin America Pneumococcal Vaccines Market Value (US$ Mn), By Distribution Channel 2012-2017
FIG. 36 Latin America Pneumococcal Vaccines Market Value (US$ Mn), By Distribution Channel 2018-2026
FIG. 37 Europe Pneumococcal Vaccines Market Value (US$ Mn), By Country 2012-2017
FIG. 38 Europe Pneumococcal Vaccines Market Value (US$ Mn), By Country 2018-2026
FIG. 39 Europe Pneumococcal Vaccines Market Value (US$ Mn), By Product Type 2012-2017
FIG. 40 Europe Pneumococcal Vaccines Market Value (US$ Mn), By Product Type 2018-2026
FIG. 41 Europe Pneumococcal Vaccines Market Value (US$ Mn), By Distribution Channel 2012-2017
FIG. 42 Europe Pneumococcal Vaccines Market Value (US$ Mn), By Distribution Channel 2018-2026
FIG. 43 Japan Pneumococcal Vaccines Market Value (US$ Mn), By Country 2012-2017
FIG. 44 Japan Pneumococcal Vaccines Market Value (US$ Mn), By Country 2018-2026
FIG. 45 Japan Pneumococcal Vaccines Market Value (US$ Mn), By Product Type 2012-2017
FIG. 46 Japan Pneumococcal Vaccines Market Value (US$ Mn), By Product Type 2018-2026
FIG. 47 Japan Pneumococcal Vaccines Market Value (US$ Mn), By 2012-2017
FIG. 48 Japan Pneumococcal Vaccines Market Value (US$ Mn), By Distribution Channel 2018-2026
FIG. 49 APEJ Pneumococcal Vaccines Market Value (US$ Mn), By Country 2012-2017
FIG. 50 APEJ Pneumococcal Vaccines Market Value (US$ Mn), By Country 2018-2026
FIG. 51 APEJ Pneumococcal Vaccines Market Value (US$ Mn), By Product Type 2012-2017
FIG. 52 APEJ Pneumococcal Vaccines Market Value (US$ Mn), By Product Type 2018-2026
FIG. 53 APEJ Pneumococcal Vaccines Market Value (US$ Mn), By Distribution Channel 2012-2017
FIG. 54 APEJ Pneumococcal Vaccines Market Value (US$ Mn), By Distribution Channel 2018-2026
FIG. 55 MEA Pneumococcal Vaccines Market Value (US$ Mn), By Country 2012-2017
FIG. 56 MEA Pneumococcal Vaccines Market Value (US$ Mn), By Country 2018-2026
FIG. 57 MEA Pneumococcal Vaccines Market Value (US$ Mn), By Product Type 2012-2017
FIG. 58 MEA Pneumococcal Vaccines Market Value (US$ Mn), By Product Type 2018-2026
FIG. 59 MEA Pneumococcal Vaccines Market Value (US$ Mn), By Distribution Channel 2012-2017
FIG. 60 MEA Pneumococcal Vaccines Market Value (US$ Mn), By Distribution Channel 2018-2026
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Pneumococcal Vaccines Market
